Novel Naturally Occurring Mutations of Enterovirus 71 Associated With Disease Severity
Infection with the re-emerging enterovirus 71 (EV-A71) is associated with a wide range of disease severity, including herpangina, encephalitis, and cardiopulmonary failure. At present, there is no FDA-approved therapeutics for EV-A71. Early diagnosis for the high-risk children is the key to successf...
Main Authors: | Chih-Shin Chang, Chun-Che Liao, An-Ting Liou, Yi-Chun Chou, Ya-Yen Yu, Chi-Yung Lin, Jen-Shiou Lin, Ching-Shu Suen, Ming-Jing Hwang, Chiaho Shih |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2020.610568/full |
Similar Items
-
Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy
by: Chiaho Shih, et al.
Published: (2018-11-01) -
Valine/isoleucine variants drive selective pressure in the VP1 sequence of EV-A71 enteroviruses
by: Nghia Ngu Duy, et al.
Published: (2017-05-01) -
Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model
by: An-Ting Liou, et al.
Published: (2019-11-01) -
Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71
by: Qi Tang, et al.
Published: (2022-04-01) -
VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
by: Fang-Hong Chen, et al.
Published: (2019-11-01)